Learn more about the issue with the HLS Set Advanced, background, FDA recommendations and FDA actionsLink to original article Abbott Trifecta Valves: Potential Risk of Early Structural Valve Deterioration- Letter to Health Care Providers Apotex Corp. Issues Voluntary Nationwide Recall of Brimonidine Tartrate Ophthalmic Solution, 0.15% Due to Cracks that Have Developed in Some of the Units Caps of the Bottles Share Print Please login or register to post comments.